Previous 10 | Next 10 |
2024-01-20 08:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the Maxim Group 2024 Healthcare IT Virtual Conference, being held January 24-25, 2024. Management will participate in a virtual firesid...
2024-01-11 16:49:58 ET Summary LifeMD expects a 38% increase in revenues for 2024, driven by its new telehealth operation for GLP-1 obesity drugs. Despite this, the stock is down significantly due to concerns over Eli Lilly direct marketing its GLP-1 obesity drugs. These fears are...
2024-01-08 10:52:23 ET More on LifeMD, Inc. LifeMD: Medifast Partnership Further Validates Weight Management Program LifeMD: My Tech Pick For 2024 And Its 12% Yielding Preferreds LifeMD Is The Stock To Play The Mega GLP-1 Drug Trend Eli Lilly to offer obesity...
Revenue expected to be between $195 and $205 million, represents a 31% to 38% increase over the midpoint of 2023 guidance. Adjusted EBITDA expected to be between $18 and $22 million, representing an increase of 71% to 110% over the midpoint of 2023 guidance. Positive full-year free cash...
2024-01-05 08:11:36 ET Ainos ( AIMD ) +150% . Safe and Green Development ( SGD ) +65% . Duos Technologies Group ( DUOT ) +12% . Immunic ( IMUX ) +17% announces private placement of up to $240 million. Fusion Pharmaceuti...
2024-01-04 12:43:30 ET More on Him & Hers, LifeMD, etc. Hims & Hers Health: Faultless, Ready To Go Higher Hims & Hers: New Weight Loss Category Is A Prescription For Explosive Growth And Upward Revisions Hims & Hers Health: Promising Catalysts To Driv...
2024-01-04 12:34:16 ET More on Mid-day movers & Stocks. Relmada Therapeutics, Inc. (RLMD) Q3 2023 Earnings Call Transcript Relmada And REL-1017: Intriguing Underlying Efficacy In MDD Ahead Of Eventful 2024 Avenue Therapeutics GAAP EPS of $0.06 beats by $0.32 ...
2024-01-04 10:00:14 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...
2024-01-03 15:59:48 ET More on LifeMD, Inc. 8.875% CUM PFD A LifeMD: My Tech Pick For 2024 And Its 12% Yielding Preferreds LifeMD, Inc. (LFMD) Q3 2023 Earnings Call Transcript LifeMD, Inc. 2023 Q3 - Results - Earnings Call Presentation Historical earnings dat...
News, Short Squeeze, Breakout and More Instantly...
LifeMD Inc. Company Name:
LFMD Stock Symbol:
NASDAQ Market:
Shares of Duolingo, Inc. (NASDAQ:DUOL) fell sharply during Thursday's session after the company reported first quarter financial results. Duol...
U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Thursday. Shares of Exact Sciences Corporation (NASDA...
First quarter revenue increased 33% year-over-year to $44.1 million with telehealth revenue growing 53% versus the year-ago period. Raising full-year revenue guidance to at least $205 million, up from prior guidance of at least $200 million. Growth in all business segments, with weight ...